The Autonomic and Catecholamine Healthspan Institute (ACHI) has been created to advance understanding of autonomic and catecholamine-related disorders, foster a more coherent clinical and scientific framework for the field, and enhance training of clinicians who diagnose and manage patients with dysautonomias.

ACHI is grounded in extensive expertise in autonomic medicine and long experience in patient-oriented research on physiological, neurochemical, neuroimaging, and other biomarkers that clarify mechanisms, improve diagnosis, and identify opportunities for prevention, delay, and mitigation of dysautonomias and diseases involving catecholamine systems of the body.